HEMONTO A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.8% 0.8% 0.8% 0.8% 0.8%  
Bankruptcy risk  2.3% 1.5% 1.8% 1.4% 1.3%  
Credit score (0-100)  65 75 70 76 80  
Credit rating  BBB A A A A  
Credit limit (kDKK)  0.4 109.7 2.8 128.0 226.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  22,238 26,126 17,688 19,365 19,084  
EBITDA  5,184 5,016 526 2,959 3,594  
EBIT  4,818 4,561 526 2,812 3,447  
Pre-tax profit (PTP)  4,812.2 4,602.6 654.5 2,873.2 3,734.4  
Net earnings  4,148.4 4,139.9 436.3 2,228.0 2,956.8  
Pre-tax profit without non-rec. items  4,812 4,603 655 2,873 3,734  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  17.0 16.0 442 295 147  
Shareholders equity total  8,330 12,470 2,936 11,670 9,627  
Interest-bearing liabilities  0.0 20,005 8,857 0.0 13.5  
Balance sheet total (assets)  17,557 49,057 17,602 15,759 13,360  

Net Debt  -5,889 -3,087 7,055 -6,065 -3,531  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  22,238 26,126 17,688 19,365 19,084  
Gross profit growth  6.6% 17.5% -32.3% 9.5% -1.4%  
Employees  35 41 26 20 21  
Employee growth %  -7.9% 17.1% -36.6% -23.1% 5.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  17,557 49,057 17,602 15,759 13,360  
Balance sheet change%  113.9% 179.4% -64.1% -10.5% -15.2%  
Added value  5,183.8 5,015.8 526.2 2,811.9 3,594.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -603 18,022 -18,055 -295 -295  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  21.7% 17.5% 3.0% 14.5% 18.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  37.8% 14.1% 2.1% 18.4% 25.7%  
ROI %  63.4% 20.5% 2.9% 26.2% 35.1%  
ROE %  66.3% 39.8% 5.7% 30.5% 27.8%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  50.5% 25.4% 16.7% 74.1% 72.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -113.6% -61.5% 1,340.6% -204.9% -98.2%  
Gearing %  0.0% 160.4% 301.6% 0.0% 0.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.8% 0.2% 4.5% 125.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.8 0.9 1.2 4.4 4.2  
Current Ratio  1.6 0.9 1.2 4.4 4.2  
Cash and cash equivalent  5,888.6 23,091.5 1,802.1 6,064.9 3,544.4  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  3,874.1 -3,974.2 2,681.9 11,562.3 9,607.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  148 122 20 141 171  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  148 122 20 148 171  
EBIT / employee  138 111 20 141 164  
Net earnings / employee  119 101 17 111 141